AMS at a Glance
Advanced Medical Solutions Group plc is a leading developer and manufacturer of innovative and technologically advanced products for the global surgical, woundcare and wound closure markets. Our strategy is based around:
- Growth - Expanding our global presence
- Innovation - Designing and developing leading products
- Value - Offering cost-effective product solutions
Full Year End31 December 2016
Half Year Results14 September 2016
Trading Update5 July 2016
Half Year End30 June 2016
Final Dividend Payment10 June 2016
AGM2 June 2016
Annual Report & Notice of AGM3 May 2016
Advanced Medical Solutions Group plc is pleased to announce they have been awarded the Partnership with the NHS award at the Medilink North West... Read More
Latest Financial Highlights
Group revenue increased by 9% to £68.6 million (2014: £63.0 million), representing growth of 11% on a constant currency basis and an increase in adjusted profit before tax of 12% to £17.4 million (2014: £15.6 million).
The strong cash flow generation of the Group was again evident and we ended the year with net cash of £34.2 million (2014: £17.3 million). We continue to be in robust financial health and are well positioned to invest in internal and external opportunities in line with the Group’s strategy.
The performance of LiquiBand® in the US was particularly strong. We continue to gain market share and are fast approaching our initial goal of building a 20% market share with our LiquiBand® range in the US. We are also pleased with the success of our LiquiBand® Fix8™ hernia mesh fixation device, our first device using medical adhesive inside the body. It is now being sold in 20 countries and has achieved £1 million of sales in its first full year since launch.
We have also received a number of product and market approvals in the year, demonstrating our continued success in innovation, with launches planned in 2016, supporting the sales growth in the Group.